Accentia Biopharmaceuticals, Inc.

Accentia Biopharmaceuticals, Inc.

Accentia Biopharmaceuticals, Inc. (Accentia) is a biopharmaceutical company focused on the development and commercialization of late-stage, targeted therapeutic clinical products in the areas of respiratory disease and oncology. The Company operates in two segments: Biopharmaceutical Products and Services, and Specialty Pharmaceuticals. The Biopharmaceutical Products and Services segment develops late-stage biopharmaceutical products with an emphasis on the respiratory and oncology therapeutic areas. The products developed in this segment are SinuNase, BiovaxID and Revimmune. This segment also includes the Company’s consulting business, which provides a range of services relating to biopharmaceutical product development, and its biologics products business. The Specialty Pharmaceuticals segment markets and sells pharmaceutical products that are developed primarily by its third-party development partners. In this segment, Accentia sells the Respi~TANN, SinuTest and Zinotic.

Contact Details

Office Address

Accentia Biopharmaceuticals, Inc.
324 South Hyde Park Avenue, Suite 350
Tampa, FL, USA 33606
Phone: (813) 864-2554
Fax: (813) 258-6912


Chairman and CEO

Francis E. O'Donnell Jr.

President, General Counsel, and Director

Samuel S. (Sam) Duffey

Business Reviews for Accentia Biopharmaceuticals, Inc.

Related Companies